Följ oss

Nyheter

The UK to enter the economic doldrums

Publicerad

den

The UK to enter the economic doldrums weaker loan growth, sterling weakness, squeezed corporate margins and negative real wages are likely to push the UK

ETF Securities Macro & Equities Research: The UK to enter the economic doldrums

Highlights

  • A combination of weaker loan growth, sterling weakness, squeezed corporate margins and negative real wages are likely to push the UK into a period of very low growth in the coming year.UK corporates have seen a substantial deterioration in interest cover, and falling earnings caused by a weakening economy are likely to exacerbate the deteriorating economic growth outlook.More cyclical sectors such as mining tend to be much more vulnerable, as does the real estate sector, which tends to decline by 4% over a 6-month period.

Our UK business cycle indicator

The UK’s economic growth prospects have come in to question in recent months after tense Brexit negotiations. Looking at the economy since the UK exited recession in February 2010 it has certainly been the weakest recovery of the 5 post recession recoveries since the 1950’s, but by no means the longest one.

(Click to enlarge)

We see evidence of weakness in the UK economy but this isn’t evident in the current GDP growth figures. We believe that due to the uniqueness of Brexit and its potential impact on the business cycle and currencies it is necessary to have a more focussed economic growth indicator. Consequently, we have developed our own economic barometer that focusses on the business cycle, corporate margins, loan growth and wages to measure turning points in economic data.

Using a combination of the well-known Conference Board Leading Economic Indicator (LEI), consumer price inflation less producer price inflation (CPI-PPI) to capture corporate margins, the British Bankers Association (BBA) loan growth data and real wage growth, it has successfully captured the business cycle.

(Click to enlarge)

Our business cycle indicator is not entirely correlated with GDP growth, typically taking longer to recover than GDP growth, we believe this reflects the delay in looser monetary policy transmitting into the corporate lending environment. For example, it wasn’t until the introduction of the second and third rounds of quantitative easing in 2011 and 2012 that the UK lending environment began to markedly improve, and therefore the business cycle improve.

We can blame Brexit

Sadly, this economic improvement looks to be coming to an abrupt end – our cycle indicator immediately began deteriorating in March 2016, after the first set of data became available following the announcement of the EU referendum. BBA loan growth began to weaken and the LEI began to flatten. Furthermore, the weaker sterling, caused by the Brexit vote has pushed up producer prices, forcing import costs higher and consequently squeezing corporate margins. We have also seen further declines in loan growth leading to a steady decline in the UK’s growth prospects. Higher inflation has also put further pressure on wages, with real wage growth now being negative for the fourth month in a row, further constricting consumers’ spending power.

Alarmingly, our business cycle indicator now suggests the UK could slip in to a period of very low growth in the coming year. We believe only a continued strong recovery in sterling, a recovery in loan growth and wage growth would turn around the UK’s fortunes. We are reluctant to state that a recession is likely at this point as it remains very unclear how the Brexit negotiations will play-out.

The market implications

In our report, Vulnerabilities exposed by rising interest rates, from a regional perspective we find, like households, that Europe and the US have the healthiest interest coverage ratios, while UK corporates have seen a substantial deterioration in interest cover, having falling from 9x in 2012 to just 3.4x today. The FTSE is therefore much more vulnerable to interest rate rises and falling earnings caused by a weakening economy, potentially exacerbating the economic growth outlook. Within the UK, we find the most vulnerable sectors are resource and property related sectors.

(Click to enlarge)

Historically FTSE 350 performance has varied at various stages through the economic cycle. Breaking down the cycle in to four components, we find distinct performance differences within sectors. The FTSE 350 tends to perform the best when the business cycle is negative but is beginning to rise and performs the poorest when the cycle begins to rollover after a period of strong economic performance.

The countercyclical nature of equity market performance is due to the bubble of optimism popping, when equities are usually over extended from a valuation standpoint. Valuations at the beginning of 2017 were at their highest since the credit crisis but the recent weak sterling has increased valuations due to inflating overseas source earnings.

(Click to enlarge)

We see the positive impact of currency on equity valuations as transitory. Our cycle indicator highlights the UK growth outlook is deteriorating and is likely to turn negative, and in such a scenario the FTSE350 has historically risen by 2.2% over a 6 month period. The best performing sectors at this stage tend to be defensive sectors such as utilities and defence contractors and those sectors that can deliver cost efficiencies for corporates such as software and computer services.

(Click to enlarge)

More cyclical sectors such as mining tend to be much more vulnerable, as does the real estate sector, which tends to decline by 4% over a 6-month period. These also happen to be the sectors which are the most over-leveraged from an interest coverage perspective.

We believe the UK’s economic growth prospects are very contingent on economically beneficial negotiations with the EU and a very cautious approach from the Bank of England, as a policy error or a bad deal could tip the UK into recession.

For more information contact:

ETF Securities Research team
ETF Securities (UK) Limited
T +44 (0) 207 448 4336
E info@etfsecurities.com

Important Information

This communication has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by ETF Securities (UK) Limited (“ETFS UK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority (the “FCA”).

Fortsätt läsa
Annons
Klicka för att kommentera

Skriv en kommentar

Din e-postadress kommer inte publiceras. Obligatoriska fält är märkta *

Nyheter

Fastställd utdelning i MONTDIV april 2025

Publicerad

den

Idag fastställdes utdelningen i MONTDIV april 2025. Montrose Global Monthly Dividend MSCI World UCITS ETF (MONTDIV ETF) fastställdes till 0,39465 kronor per andel. Utdelningen i MONTDIV april 2025 beräknas betalas ut den 12 maj 2025.

Idag fastställdes utdelningen i MONTDIV april 2025. Montrose Global Monthly Dividend MSCI World UCITS ETF (MONTDIV ETF) fastställdes till 0,39465 kronor per andel. Utdelningen i MONTDIV april 2025 beräknas betalas ut den 12 maj 2025.

Handla MONTDIV ETF

Montrose Global Monthly Dividend MSCI World UCITS ETF (MONTDIV ETF) är en europeisk börshandlad fond. Denna fond handlas på Nasdaq Stockholm.

Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel  NordnetSAVRDEGIRO och Avanza.

Fortsätt läsa

Nyheter

WELG ETF en satsning på healthcareföretag världen över

Publicerad

den

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) (WELG ETF) med ISIN IE000JKS50V3, strävar efter att spåra S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. Det S&P-utvecklade ex-Korea LargeMidCap Sustainability Enhanced Health Care-indexet spårar stora och medelstora företag från hälso- och sjukvårdssektorn. Aktierna som ingår filtreras enligt ESG-kriterier (miljö, social och bolagsstyrning).

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) (WELG ETF) med ISIN IE000JKS50V3, strävar efter att spåra S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. Det S&P-utvecklade ex-Korea LargeMidCap Sustainability Enhanced Health Care-indexet spårar stora och medelstora företag från hälso- och sjukvårdssektorn. Aktierna som ingår filtreras enligt ESG-kriterier (miljö, social och bolagsstyrning).

Den börshandlade fondens TER (total cost ratio) uppgår till 0,18 % p.a. Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) är den billigaste ETF som följer S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. ETFen replikerar det underliggande indexets prestanda genom fullständig replikering (köper alla indexbeståndsdelar). Utdelningarna i ETFen delas ut till investerarna (Årligen).

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) är en mycket liten ETF med 17 miljoner euro förvaltade tillgångar. ETFen lanserades den 20 september 2022 och har sin hemvist i Irland.

Investeringsmål

AMUNDI S&P GLOBAL HEALTH CARE ESG UCITS ETF DR – EUR (D) försöker replikera, så nära som möjligt, resultatet av S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index (Netto Total Return Index). Denna ETF har exponering mot stora och medelstora företag i utvecklade länder. Den innehåller uteslutningskriterier för tobak, kontroversiella vapen, civila och militära handeldvapen, termiskt kol, olja och gas (inkl. Arctic Oil & Gas), oljesand, skiffergas. Den är också utformad för att välja ut och omvikta företag för att tillsammans förbättra hållbarhet och ESG-profiler, uppfylla miljömål och minska koldioxidavtrycket.

Handla WELG ETF

Amundi S&P Global Health Care ESG UCITS ETF DR EUR (D) (WELG ETF) är en europeisk börshandlad fond. Denna fond handlas på flera olika börser, till exempel Deutsche Boerse Xetra.

Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel DEGIRONordnet, Aktieinvest och Avanza.

Börsnoteringar

BörsValutaKortnamn
gettexEURWELG
XETRAUSDWELZ
XETRAEURWELG

Största innehav

Denna fond använder fysisk replikering för att spåra indexets prestanda.

NamnValutaViktSektor
ELI LILLY & COUSD10.29 %Health Care
UNITEDHEALTH GROUP INCUSD7.99 %Health Care
NOVO NORDISK A/S-BDKK6.32 %Health Care
ABBVIE INCUSD6.12 %Health Care
ASTRAZENECA GBPGBP5.26 %Health Care
ROCHE HOLDING AG – GENUSSSCHF4.18 %Health Care
MERCK & CO. INC.USD3.93 %Health Care
NOVARTIS AG-REGCHF3.70 %Health Care
ABBOTT LABORATORIESUSD3.43 %Health Care
SANOFIEUR2.58 %Health Care

Innehav kan komma att förändras

Fortsätt läsa

Nyheter

Amundi noterar ETF för globala företagsobligationer

Publicerad

den

Amundi Global Corporate Bond UCITS ETF investerar globalt i företagsobligationer med fast ränta, denominerade i lokal valuta och har en investment grade-rating. De måste ha en återstående löptid på minst ett år.

Amundi Global Corporate Bond UCITS ETF investerar globalt i företagsobligationer med fast ränta, denominerade i lokal valuta och har en investment grade-rating. De måste ha en återstående löptid på minst ett år.

Andelsklassen är valutasäkrad mot amerikanska dollar och delar ut avkastningen.

NamnISIN
Kortnamn
KostnadUtdelnings-
policy
Amundi Global Corporate Bond UCITS ETF USD Hedged DistLU2996613266
USBG (USD)
0,17%Utdelande

Produktutbudet inom Deutsche Börses ETF- och ETP-segment omfattar för närvarande totalt 2 405 ETFer, 198 ETCer och 256 ETNer. Med detta urval och en genomsnittlig månatlig handelsvolym på mer än 21 miljarder euro är Xetra den ledande handelsplatsen för ETFer och ETPer i Europa.

Fortsätt läsa

Populära